INPR
PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
08/05/2026
Voltar para busca
Dado oficial do USPTO
CITELINE
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Snapshot rápido
CITELINE
ST13
US500000079103969Classe
9, 16, 41, 42, 44
Pedido
79103969
Registro
4762279
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
103
Atualização mais recente
09/05/2026
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
9, 16, 41, 42, 44
Data de depósito
31/03/2011
Data de registro
30/06/2015
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
08/09/2025
Última transação
09/05/2026
Escritório responsável
United States Patent and Trademark Office
Código da situação
706
Cadastro oficial
Principal Register
Código do desenho
4
Tipo de titular
99
Localização do titular
London, GB
Examinador
FENNESSY, EDWARD JOHN
Unidade examinadora
L10
Localização atual
TMEG LAW OFFICE 101
Titulares e representantes
Titulares
PHARMA INTELLIGENCE U.K. LIMITED
Caerus US 1 Inc.
Informa Business Intelligence, Inc.
Citeline, Inc.
Informa UK Limited
Representantes
Jessica S. Sachs Harness, Dickey & Pierce, P.L.C.
Classificação técnica
Classes Nice
Classe 9Classe 16Classe 41Classe 42Classe 44
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 9
Apparatus for recordingtransmission or reproduction of sound or images; blank magnetic data carriersprerecorded magnetic data carriers featuring information and data in the fields of medical researchclinical trialspharmaceutical research and developmentpharmaceutical drug development serviceshealthcare; blank recording optical discs; pre-recorded CDsvideo tapeslaser disks and DVDs featuring information in the fields of medical researchclinical trialspharmaceutical research and developmentpharmaceutical drug development serviceshealthcare; computer software for use in database management in the fields of medical researchclinical trialspharmaceutical research and developmentpharmaceutical drug development serviceshealthcare; downloadable computer software for use in database management in the fields of medical researchclinical trialspharmaceutical research and developmentpharmaceutical drug development serviceshealthcare; computer software for use in database management in the fields of medical researchclinical trialspharmaceutical research and developmentpharmaceutical drug development serviceshealthcare and manuals in electronic format sold as a unit; computer software for the provision of information relating to medical researchclinical trialspharmaceutical research and developmentpharmaceutical drug development serviceshealthcare; computer software for the analysis of information and data relating to medical researchclinical trialspharmaceutical research and developmentpharmaceutical drug development serviceshealthcare; downloadable electronic publications in the nature of newslettersreportsdirectories and bulletins in the fields of medical researchclinical trialspharmaceutical research and developmentpharmaceutical drug development serviceshealthcare from databases or the internet; downloadable electronic publications and informationnewslettersreportsdirectories and bulletins in the fields of medical researchclinical trialspharmaceutical research and developmentpharmaceutical drug development serviceshealthcare provided on-line from databases or the internet; computer programs featuring programming languages in electronic form for use in database management in the fields of medical researchclinical trialspharmaceutical research and developmentpharmaceutical drug development serviceshealthcare; prerecorded magneticelectronic or optical data carriers featuring information on medical researchclinical trialspharmaceutical research and developmentpharmaceutical drug development serviceshealthcare; electronic publicationsinstruction manuals recorded on computer media relating to use of computers and to dataall recorded magneticallyoptically or electronically ; magneticoptical and electronic data recording apparatus for recording of soundimages or data
Classe 16
Paper and cardboard; goods made from paper or cardboard not included in other classesboxescartonsstorage containerspackaging containers; printed materialsjournalsnewslettersreportsdirectories featuring information on medical researchclinical trialspharmaceutical research and developmentpharmaceutical drug development serviceshealthcare; printed instructional materials in the field of computer software and programmes; book-binding material; photographs; stationery; printed instructionaleducationalteaching materials in the fields of medical researchclinical trialspharmaceutical research and developmentpharmaceutical drug development serviceshealthcare
Classe 41
Education servicesproviding educational seminarsconferencesclasses and workshops in the fields of medical researchclinical trialspharmaceutical research and developmentpharmaceutical drug development serviceshealthcare; Training services in the fields of medical researchclinical trialspharmaceutical research and developmentpharmaceutical drug development serviceshealthcare; entertainment and recreational servicessporting and cultural eventstraining and educational conferencescoursesseminars and exhibitions in the fields of medical researchclinical trialspharmaceutical research and developmentpharmaceutical drug development serviceshealthcare; Publishing and issuing of scientific papers in the fields of medical researchclinical trialspharmaceutical research and developmentpharmaceutical drug development serviceshealthcare; Electronic publishing servicespublication of text and graphic works of others online featuring information on medical researchclinical trialspharmaceutical research and developmentpharmaceutical drug development serviceshealthcare ; the provision of news online in the nature of news agenciesgathering and dissemination of news; Nondownloadable electronic publications in the nature of journalsnewslettersreportsdirectories in the fields of medical researchclinical trialspharmaceutical research and developmentpharmaceutical drug development serviceshealthcare via the Internet
Classe 42
Medical services; advisory medical services and the provision of medical information; dentistry services; advisory medical services and the provision of information relating to dentistry; advisory services and the provision of information relating to health; consultation in the field of health risk assessmentprediction and assessment of health risks to public and private agenciesfacilitiesindividuals and locations following the administration of chemicalbiological radiological or nuclear materials; providing medical informationconsultancy and advisory services in the field of pharmaceuticals; medical information in the field of pharmaceuticals; dispensing of pharmaceuticals; veterinary services; medical testing services for diagnostic and treatment purposes; surgical treatment services; advisory services and the provision of medical information relating to surgery; advisory services and the provision of medical information relating to cosmetic surgery; advisory services and the provision of medical information relating to cosmetic treatment; hygienic and beauty care for human beings; hygienic and beauty care for animals; beauty therapy servicesmedicalhygienic and beauty care services; informationconsultancy and advisory services relating to all the aforesaid services; informationconsultancy and advisory services in the field of medical researchclinical trialspharmaceutical research and developmentpharmaceutical drug development serviceshealthcare relating to all the aforesaid services provided on-line
Classe 44
Medical services; advisory medical services and the provision of medical information; dentistry services; advisory medical services and the provision of information relating to dentistry; advisory services and the provision of information relating to health; consultation in the field of health risk assessmentprediction and assessment of health risks to public and private agenciesfacilitiesindividuals and locations following the administration of chemicalbiological radiological or nuclear materials; providing medical informationconsultancy and advisory services in the field of pharmaceuticals; medical information in the field of pharmaceuticals; dispensing of pharmaceuticals; veterinary services; medical testing services for diagnostic and treatment purposes; surgical treatment services; advisory services and the provision of medical information relating to surgery; advisory services and the provision of medical information relating to cosmetic surgery; advisory services and the provision of medical information relating to cosmetic treatment; hygienic and beauty care for human beings; hygienic and beauty care for animals; beauty therapy servicesmedicalhygienic and beauty care services; informationconsultancy and advisory services relating to all the aforesaid services; informationconsultancy and advisory services in the field of medical researchclinical trialspharmaceutical research and developmentpharmaceutical drug development serviceshealthcare relating to all the aforesaid services provided on-line
Publicações
Histórico de despachos e eventos da marca no USPTO.
103 publicações encontradas
NA71
NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
08/09/2025
71AG
REGISTERED-SEC.71 ACCEPTED
08/09/2025
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
08/09/2025
ES71
TEAS SECTION 71 RECEIVED
02/06/2025
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
30/05/2025
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
30/05/2025
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
30/05/2025
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
30/05/2025
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
30/05/2025
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
30/05/2025
NREP
NEW REPRESENTATIVE AT IB RECEIVED
04/04/2025
INNP
PARTIAL INVALIDATION PROCESSED BY THE IB
29/11/2024
INPS
PARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
19/09/2024
INPC
INVALIDATION PROCESSED
19/09/2024
INPR
PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
13/09/2024
REM4
COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED
30/06/2024
DCPN
CHANGE OF OWNER RECEIVED FROM IB
07/03/2024
NA75
NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED
12/01/2024
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
12/01/2024
PRAN
POST REGISTRATION ACTION MAILED NO RESPONSE REQUIRED
12/01/2024
C75P
REGISTERED - PARTIAL SEC. 71 ACCEPTED & SEC. 15 ACK.
12/01/2024
PRA7
REGISTERED - SEC. 7 REQUEST ABANDONED
12/01/2024
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
10/01/2024
INNA
INVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE
24/03/2023
CHLD
CHANGE OF OWNER RECEIVED FROM IB
25/02/2023
INPR
PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
07/02/2023
EROP
TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
06/12/2022
ES7R
TEAS SECTION 7 REQUEST RECEIVED
30/11/2022
PR75
POST REGISTRATION ACTION MAILED - SEC. 71 & 15
07/06/2022
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
06/06/2022
ES75
TEAS SECTION 71 & 15 RECEIVED
29/12/2021
RNWL
INTERNATIONAL REGISTRATION RENEWED
20/05/2021
REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
30/06/2020
ADCH
CHANGE OF NAME/ADDRESS REC'D FROM IB
26/01/2017
CHLD
CHANGE OF OWNER RECEIVED FROM IB
05/01/2017
NREP
NEW REPRESENTATIVE AT IB RECEIVED
04/08/2016
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
17/11/2015
FICS
FINAL DISPOSITION NOTICE SENT TO IB
26/10/2015
FIMP
FINAL DISPOSITION PROCESSED
26/10/2015
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
30/09/2015
R.PR
REGISTERED-PRINCIPAL REGISTER
30/06/2015
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
14/04/2015
PUBO
PUBLISHED FOR OPPOSITION
14/04/2015
GPNX
NOTIFICATION PROCESSED BY IB
10/04/2015
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
25/03/2015
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
25/03/2015
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
25/03/2015
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
06/03/2015
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
05/03/2015
ALIE
ASSIGNED TO LIE
20/01/2015
CHLD
CHANGE OF OWNER RECEIVED FROM IB
16/10/2014
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
16/07/2014
GNSL
LETTER OF SUSPENSION E-MAILED
16/07/2014
CNSL
SUSPENSION LETTER WRITTEN
16/07/2014
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
08/07/2014
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
08/07/2014
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
08/07/2014
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
09/01/2014
GNFR
FINAL REFUSAL E-MAILED
09/01/2014
CNFR
FINAL REFUSAL WRITTEN
09/01/2014
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
23/12/2013
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
23/12/2013
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
23/12/2013
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
28/06/2013
GNRT
NON-FINAL ACTION E-MAILED
28/06/2013
CNRT
NON-FINAL ACTION WRITTEN
28/06/2013
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
28/05/2013
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
28/05/2013
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
28/05/2013
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
20/04/2013
NREP
NEW REPRESENTATIVE AT IB RECEIVED
05/04/2013
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
03/04/2013
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
03/04/2013
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
27/11/2012
GNRT
NON-FINAL ACTION E-MAILED
27/11/2012
CNRT
NON-FINAL ACTION WRITTEN
27/11/2012
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
01/11/2012
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
31/10/2012
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
31/10/2012
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
08/06/2012
GNSL
LETTER OF SUSPENSION E-MAILED
08/06/2012
CNSL
SUSPENSION LETTER WRITTEN
08/06/2012
LIMN
LIMITATION FROM THE IB EXAMINED, NO ACTION IS NEEDED
06/06/2012
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
25/05/2012
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
25/05/2012
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
09/05/2012
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
09/05/2012
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
09/05/2012
LIMG
LIMITATION OF GOODS RECEIVED FROM IB
04/05/2012
RFNT
REFUSAL PROCESSED BY IB
19/12/2011
RFNT
REFUSAL PROCESSED BY IB
27/11/2011
MAFR
APPLICATION FILING RECEIPT MAILED
11/11/2011
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
10/11/2011
RFRR
REFUSAL PROCESSED BY MPU
10/11/2011
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
10/11/2011
CNRT
NON-FINAL ACTION WRITTEN
09/11/2011
RFRR
REFUSAL PROCESSED BY MPU
08/11/2011
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
08/11/2011
CNRT
NON-FINAL ACTION WRITTEN
07/11/2011
DOCK
ASSIGNED TO EXAMINER
07/11/2011
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
07/11/2011
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
03/11/2011
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace CITELINE ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.